Literature DB >> 1920018

Tissue levels of bone resorptive cytokines in periodontal disease.

P Stashenko1, J J Jandinski, P Fujiyoshi, J Rynar, S S Socransky.   

Abstract

The levels of 3 bone resorptive cytokines, interleukin 1 alpha (IL-1 alpha), IL-1 beta, and tumor necrosis factor alpha (TNF alpha), were assessed in tissues from sites of periodontal disease. As determined by ELISA of tissue extracts, IL-1 beta and TNF alpha were detected in all diseased sites, whereas IL-1 alpha was present in 8/22 sites, IL-1 beta was present in highest concentration (mean +/- SEM: 11,695 +/- 2,888 pg/ml; 672 pM), followed by TNF alpha (434 +/- 135 pg/ml; 26 pM), and IL-1 alpha (342 +/- 160 pg/ml; 20 pM). The levels of all 3 mediators were significantly lower in clinically healthy tissues. There was a highly significant correlation between levels of IL-1 beta and TNF alpha (rs = 0.61, P less than 0.001), suggesting coordinated expression of these 2 mediators. The numbers of cells containing each mediator was also determined by indirect immunofluorescence on frozen tissue sections. Consistent with findings from tissue extracts, IL-1 beta-containing cells were present in approximately 5-fold higher numbers than TNF alpha-containing cells, and 40-fold higher numbers than IL-1-alpha-containing cells. Taken together with previous findings, these results indicate that IL-1 beta is likely to be an important mediator in the pathogenesis of periodontal disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1920018     DOI: 10.1902/jop.1991.62.8.504

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  57 in total

Review 1.  Novel host response therapeutic approaches to treat periodontal diseases.

Authors:  Keith L Kirkwood; Joni A Cirelli; Jill E Rogers; William V Giannobile
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

2.  Effects of etanercept, a tumour necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats.

Authors:  R Di Paola; E Mazzon; C Muià; C Crisafulli; D Terrana; S Greco; D Britti; D Santori; G Oteri; G Cordasco; S Cuzzocrea
Journal:  Br J Pharmacol       Date:  2007-01-02       Impact factor: 8.739

3.  Porphyromonas gingivalis-induced inflammatory mediator profile in an ex vivo human whole blood model.

Authors:  C Bodet; F Chandad; D Grenier
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

4.  The effect of low-level diode laser on COX-2 gene expression in chronic periodontitis patients.

Authors:  Snezana Pesevska; Icko Gjorgoski; Kiro Ivanovski; Nikolaos K Soldatos; Nikola Angelov
Journal:  Lasers Med Sci       Date:  2017-05-18       Impact factor: 3.161

5.  Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice.

Authors:  E Lalla; I B Lamster; M Feit; L Huang; A Spessot; W Qu; T Kislinger; Y Lu; D M Stern; A M Schmidt
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

6.  Th1 biased response to a novel Porphyromonas gingivalis protein aggravates bone resorption caused by this oral pathogen.

Authors:  Onir Leshem; Suely S Kashino; Reginaldo B Gonçalves; Noriyuki Suzuki; Masao Onodera; Akira Fujimura; Hajime Sasaki; Philip Stashenko; Antonio Campos-Neto
Journal:  Microbes Infect       Date:  2008-03-25       Impact factor: 2.700

Review 7.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

8.  Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion.

Authors:  L Shapira; W A Soskolne; Y Houri; V Barak; A Halabi; A Stabholz
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Leptin potentiates Prevotella intermedia lipopolysaccharide-induced production of TNF-alpha in monocyte-derived macrophages.

Authors:  Sung-Jo Kim
Journal:  J Periodontal Implant Sci       Date:  2010-06-25       Impact factor: 2.614

10.  In vitro models of tissue penetration and destruction by Porphyromonas gingivalis.

Authors:  Elisoa Andrian; Daniel Grenier; Mahmoud Rouabhia
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.